Filing Flows › Outset Medical (OM) › Q4 2025
Outset Medical (OM) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Feb 13, 2026
Outset Medical (OM) reported revenue of $28.9M for the fourth quarter 2025 (Q4 2025), -2% from a year earlier and -2% from the quarter before. Operating margin was -61.1%, net loss $19.5M (67.5% of revenue).
Outset Medical, Q4 2025: revenue $28.9M (-2% year over year), operating margin -61.1%, net loss $19.5M, operating cash flow −$9.5M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $28.9M | -2% | -2% |
| Operating profit | −$17.6M | — | — |
| Net earnings | −$19.5M | — | — |
| Operating cash flow | −$9.5M | — | — |
What changed
Revenue was $28.9M in Q4 2025, down 2% year over year and down 2% from the previous quarter. Consumables Product was the largest line at 47% of revenue.
Gross margin was 42.4%, up 5.9 points from a year earlier. Operating costs exceeded revenue by $17.6M, an operating margin of -61.1%. Operating expenses fell 8% while revenue fell 2%. The fastest-growing cost line was General & admin (+29%). The quarter ended with a net loss of $19.5M, wider than the previous quarter's $17.8M loss.
Operating cash flow was −$9.5M. Non-cash charges added back $881K of depreciation and amortization and $4.1M of share-based compensation. Working capital and other items added $5.0M. Capital expenditures of $223K exceeded it, leaving free cash flow of −$9.7M.
Questions
What was Outset Medical's revenue in the fourth quarter 2025?
Outset Medical (OM) reported revenue of $28.9M for the fourth quarter 2025 (Q4 2025), -2% from a year earlier and -2% from the quarter before.
Was Outset Medical profitable in the fourth quarter 2025?
Operating loss was $17.6M (-61.1% of revenue) and net loss $19.5M.
Source: Outset Medical 10-K on SEC EDGAR.